Back
Top 2%
18.3%
#1
12.2%
Top 2%
11.3%
Top 35%
6.6%
Top 3%
6.6%
Top 3%
6.1%
Top 2%
4.3%
Top 4%
4.0%
Top 1%
4.0%
Top 89%
3.2%
Top 3%
2.0%
Top 3%
1.6%
Top 6%
1.4%
Top 8%
1.4%
Top 2%
1.2%
Top 23%
1.0%
Top 10%
0.7%
Top 6%
0.7%
Top 4%
0.7%
Top 2%
0.7%
Top 6%
0.7%
Spatial biomarkers of response to neoadjuvant therapy in muscle-invasive bladder cancer: the DUTRENEO trial
2025-02-10
oncology
Title + abstract only
View on medRxiv
Show abstract
Many studies have reported biomarkers predictive of response to immune checkpoint inhibitors (ICI) based on retrospective analyses. However, few clinical trials have tested their value prospectively. The DUTRENEO trial (EudraCT: 2017-002246-6) investigated whether an 18-gene Tumour Inflammation Signature (TIS) that can robustly identify patients who respond to ICI in multiple tumour types could stratify patients with localized muscle-invasive bladder cancer (MIBC) to receive neoadjuvant ICI (dur...
Predicted journal destinations
1
Nature Communications
483 training papers
2
Clinical Cancer Research
22 training papers
3
Cancers
57 training papers
4
Scientific Reports
701 training papers
5
eLife
262 training papers
6
Frontiers in Oncology
34 training papers
7
Proceedings of the National Academy of Sciences
100 training papers
8
Frontiers in Immunology
140 training papers
9
British Journal of Cancer
22 training papers
10
PLOS ONE
1737 training papers
11
Cancer Medicine
17 training papers
12
BMC Cancer
21 training papers
13
iScience
74 training papers
14
Nature Genetics
72 training papers
15
Science Translational Medicine
40 training papers
16
JAMA Network Open
125 training papers
17
Nature
58 training papers
18
Journal of Clinical Investigation
50 training papers
19
Communications Biology
36 training papers
20
Cell Reports
25 training papers
21
Communications Medicine
63 training papers